AI Summary
This article explores potential differences in organ preservation between total neoadjuvant therapy (TNT) regimens that use long-course chemoradiotherapy (LCCRT) versus short-course radiotherapy (SCRT) in rectal cancer. The study aims to define the impact of these treatment approaches on preserving organ function in rectal cancer patients. The results could have significant implications for improving patient outcomes and quality of life in this population.
Potential differences in organ preservation between total neoadjuvant therapy (TNT) regimens integrating long-course chemoradiotherapy (LCCRT) and short-course radiotherapy (SCRT) in rectal cancer remain undefined.